Leaders + Advisors
We are scientists, educators, project managers, industry experts, and business and nonprofit leaders working together to more effectively advance academic discoveries from the lab to the clinic.
Leaders
Stephen Kargotich, PhD, MBA, LLB
Executive Director
Opher Kornfeld, PhD
Managing Director of Translational Research and Development
Daria Mochly-Rosen, PhD
Chief Science and Education Advisor
Kevin Grimes, MD, MBA
Chief Clinical and Education Advisor
Translational Research Advisory Committee (TRAC)
Kevin Grimes, MD, MBA
Chief Clinical and Education Advisor, SPARK NS
Dirk Mendel, PhD
Associate Director, Translational Science, SPARK at Stanford
Daria Mochly-Rosen, PhD
Chief Science and Education Advisor, SPARK NS
Industry Advisors
Our 90+ industry expert advisors have experience in every aspect of the drug discovery and development process and long track records of success advancing academic discoveries from lab to clinic. Academic researchers in our program benefit from cohort-wide project and progress meetings attended by panels of advisors at the same time as well as one-on-one or small group mentoring in areas of need.
Clinical Operations
Venture Capital
Diagnostics & Biomarkers
Pharmacology
Legal & Licensing
Medical Affairs
Pharma Business Development
Medicinal Chemistry
Clinical Trial Design
Regulatory
Formulation
Entrepreneurship
Antibody Engineering
The SPARK NS Translational Research Program, 2027 Cohort
SPARK NS is now accepting applications from principal investigators developing therapeutics for autism and Parkinson's disease in the United States, Canada, the United Kingdom, and Europe. Deadline to apply is June 5, 2026 at 5:00 pm.
All the Details